If I've already had COVID, do I need a vaccine? And how does the immune system respond? An expert explains

covid vaccine
Credit: Pixabay/CC0 Public Domain

Over a year into the pandemic, questions around immune responses after COVID continue to confound.

One question many people are asking is whether the immunity you get from contracting COVID and recovering is enough to protect you in the future.

The answer is no, it's not.

Here's why.

Remind me, how does our immune response work?

Immune responses are innate or acquired. Innate, or short-term immunity, occurs whenthat are the body's first line of defense are activated against a pathogen like a virus or bacteria.

If the pathogen is able to cross the first line of defense, T-cells and B-cells are triggered into action. B-cells fight through secreted proteins called antibodies, specific to each pathogen. T-cells can be categorized into helper T-cells and killer T-cells. Helper T-cells "help" B-cells in making antibodies. Killer T-cells directly kill infected cells.

Once the battle is over, B-cells and T-cells develop "memory" and can recognize the invading pathogen next time. This is known as acquired or adaptive immunity, which triggers long-term protection.

当你感染会发生什么呢?内存B-cells don't just produce identical antibodies, they also produce antibody variants. These diverse set of antibodies form an elaborate security ring to fight SARS-CoV-2 variants.

Natural immunity is not enough

Getting COVID and recovering (known as "natural infection")doesn't appearto generate protection as robust as that generated after vaccination.

And thegenerated post-infection and vaccination, known as hybrid immunity, ismore potentthan either natural infection or vaccination alone.

People who have had COVID and recovered andthen been vaccinated against COVIDhave more diverse and high-quality memory B-cell responses than people who've just been vaccinated.

Studiesindicate mRNA vaccines generate a more potent immune response with previous infection, at leastagainst some variantsincluding Alpha and Beta.

And studies have shown that antibody levelswere higheramong those who'd recovered from COVID and were subsequently vaccinated than those who'd only had the infection.

内存B-cells against the coronavirus have been reported to befive to ten times higherin people vaccinated post-infection than natural infection or vaccination alone.

Is one dose enough after COVID?

Some reportshave suggested people who've had COVID need only one dose of the vaccine. Clinical trials of approved vaccinesdidn't generatebecause people who'd already had COVID were excluded from phase 3 trials.

One study from Juneshowed people with previous exposure to SARS-CoV-2 tended to mount powerful immune responses to a single mRNA shot. They didn't gain much benefit from a second jab.

A single dose of an mRNA vaccine after infection achieves similar levels of antibodies against the spike protein's receptor binding domain (which allows the virus to attach to our cells) compared to double doses of vaccination in people never exposed to SARS-CoV-2.

We need more studies to fully understand how long memory B-cell and T-cell responses will last in both groups.

Also, a single dose strategy has only been studied for mRNA-based vaccines. More data is required to understand whether one jab post-infection would be effective for all the vaccines.

At this stage, it's still good to have both doses of a COVID vaccine after recovering from COVID.

Does Delta change things?

The development of new vaccines mustkeep pacewith the evolution of the coronavirus.

At least one variant seems to have evolved enough to overtake others, Delta, which is about60% more transmissiblethan the Alpha variant. Delta ismoderately resistantto vaccines, meaning it can reduce how well the vaccines work, particularly in people who've only had one dose.

There'sno data available yetabout how effective a single jab is for people who were previously infected with Delta and recovered.

The most important thing you can do to protect yourself from Delta is to get fully vaccinated.

According to a Public Health England report, one dose of Pfizer offeredonly about 33% protectionagainst symptomatic disease with Delta, but two doses was 88% effective. Two doses was also 96% effective against hospitalization from Delta. The AstraZeneca vaccine was 92% effective against hospitalization from Delta after two doses.

A fewmanufacturers, including Pfizer, are now planning to use a potential third dose as a booster to combat the Delta variant.

Provided byThe Conversation

This article is republished fromThe Conversationunder a Creative Commons license. Read theoriginal article.The Conversation

Citation: If I've already had COVID, do I need a vaccine? And how does the immune system respond? An expert explains (2021, August 2) retrieved 2 May 2023 from //www.pyrotek-europe.com/news/2021-08-ive-covid-vaccine-immune-expert.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Delta variant makes COVID-19 vaccine even more important, even if you've already had the coronavirus

133shares

Feedback to editors